Valley Brook Capital Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Valley Brook Capital Group's MRK Position: Q2 2026 in Review
Valley Brook Capital Group held its Merck (MRK) position steady in Q2 2026 at 2,636 shares worth $339K. The position accounts for 0.19% of the portfolio, ranked #89.
Valley Brook Capital Group first reported a position in MRK in Q4 2020 and has held it in 23 quarters since. The position peaked at $1M in Q1 2024. 2,365 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Valley Brook Capital Group held 2,636 shares of Merck worth $339K as of Q2 2026.
- Valley Brook Capital Group left its Merck share count unchanged in Q2 2026.
- Merck made up 0.19% of Valley Brook Capital Group's portfolio in Q2 2026, its #89 holding.
- Valley Brook Capital Group first reported a position in Merck in Q4 2020 and has held it in 23 quarters since.
- Valley Brook Capital Group's Merck position peaked at $1M in Q1 2024.
- 2,365 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Valley Brook Capital Group's 13F filing for Q2 2026, filed 27 Jul 2026.